Paradigm Biocapital Advisors LP Portfolio Holdings

Paradigm Biocapital Advisors LP

  • $2.14 Billion
  • Q2 2025

Paradigm Biocapital Advisors LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $2.14 Billion distributed in 28 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Nuvalent, Inc. with a value of $402M, Arcellx, Inc. with a value of $306M, Merus N.V. with a value of $225M, Revolution Medicines, Inc. with a value of $224M, and Tarsus Pharmaceuticals, Inc. with a value of $121M.

Examining the 13F form we can see an increase of $191M in the current position value, from $1.95B to 2.14B.

Paradigm Biocapital Advisors LP is based out at New York, NY

Below you can find more details about Paradigm Biocapital Advisors LP portfolio as well as his latest detailed transactions.

Portfolio value $2.14 Billion
Healthcare: $2.14 Billion

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 28
  • Current Value $2.14 Billion
  • Prior Value $1.95 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 6 stocks
  • Additional Purchases 14 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Paradigm Biocapital Advisors LP Portfolio

Follow Paradigm Biocapital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email